The TransFLUas influenza transmission study in acute healthcare - recruitment rates and protocol adherence in healthcare workers and inpatients.
Asymptomatic infection
Healthcare-associated infection
Influenza
Surveillance
Transmission
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
21 May 2019
21 May 2019
Historique:
received:
22
11
2018
accepted:
01
05
2019
entrez:
23
5
2019
pubmed:
23
5
2019
medline:
6
8
2019
Statut:
epublish
Résumé
Detailed knowledge about viral respiratory disease transmission dynamics within healthcare institutions is essential for effective infection control policy and practice. In the quest to study viral transmission pathways, we aimed to investigate recruitment rates and adherence of healthcare workers (HCWs) and hospital inpatients with a study protocol that involves prospective surveillance based on daily mid-turbinate nasal swabs and illness diaries. Single center prospective surveillance of patients and HCWs in three different hospital departments of a tertiary care center during an entire influenza season in Switzerland. Inpatients and acute care HCWs were asked to provide mid-turbinate nasal swabs and illness diaries on a daily basis. Study protocol adherence and recruitment rates were the primary outcomes of interest. A total 251 participants (59 (23.5%) health care workers and 192 (76.5%) inpatients) were recruited from three different hospital wards. Recruitment rates differed between HCWs (62.1% of eligible HCWs) and inpatients (32.5%; P < 0.001), but not within HCWs (P = 0.185) or inpatients (P = 0.301) of the three departments. The total number of study-days was 7874; 2321 (29.5%) for inpatients and 5553 (70.5%) for HCWs. HCWs were followed for a median of 96 days (range, 71-96 days) and inpatients for 8 days (range, 3-77 days). HCWs provided swabs on 73% (range, 0-100%) of study days, and diaries on 77% (range 0-100%). Inpatients provided swabs and diaries for 83% (range, 0-100%) of days in hospital. In HCWs, increasing age, working in internal medicine and longer duration of total study participation were positively associated with the proportion of swabs and diaries collected. Adherence to the study protocol was significantly lower in physicians as compared to nurses for both swabs (P = 0.042) and diaries (P = 0.033). In inpatients, no association between demographic factors and adherence was detected. Conclusions Prospective surveillance of respiratory viral disease was feasible in a cohort of inpatients and HCWs over an entire influenza season, both in terms of recruitment rates and adherence to a study protocol that included daily specimen collection and illness diaries. clinicaltrials.gov NCT02478905 . Date of registration June 23, 2015.
Sections du résumé
BACKGROUND
BACKGROUND
Detailed knowledge about viral respiratory disease transmission dynamics within healthcare institutions is essential for effective infection control policy and practice. In the quest to study viral transmission pathways, we aimed to investigate recruitment rates and adherence of healthcare workers (HCWs) and hospital inpatients with a study protocol that involves prospective surveillance based on daily mid-turbinate nasal swabs and illness diaries.
METHODS
METHODS
Single center prospective surveillance of patients and HCWs in three different hospital departments of a tertiary care center during an entire influenza season in Switzerland. Inpatients and acute care HCWs were asked to provide mid-turbinate nasal swabs and illness diaries on a daily basis. Study protocol adherence and recruitment rates were the primary outcomes of interest.
RESULTS
RESULTS
A total 251 participants (59 (23.5%) health care workers and 192 (76.5%) inpatients) were recruited from three different hospital wards. Recruitment rates differed between HCWs (62.1% of eligible HCWs) and inpatients (32.5%; P < 0.001), but not within HCWs (P = 0.185) or inpatients (P = 0.301) of the three departments. The total number of study-days was 7874; 2321 (29.5%) for inpatients and 5553 (70.5%) for HCWs. HCWs were followed for a median of 96 days (range, 71-96 days) and inpatients for 8 days (range, 3-77 days). HCWs provided swabs on 73% (range, 0-100%) of study days, and diaries on 77% (range 0-100%). Inpatients provided swabs and diaries for 83% (range, 0-100%) of days in hospital. In HCWs, increasing age, working in internal medicine and longer duration of total study participation were positively associated with the proportion of swabs and diaries collected. Adherence to the study protocol was significantly lower in physicians as compared to nurses for both swabs (P = 0.042) and diaries (P = 0.033). In inpatients, no association between demographic factors and adherence was detected. Conclusions Prospective surveillance of respiratory viral disease was feasible in a cohort of inpatients and HCWs over an entire influenza season, both in terms of recruitment rates and adherence to a study protocol that included daily specimen collection and illness diaries.
TRIAL REGISTRATION
BACKGROUND
clinicaltrials.gov NCT02478905 . Date of registration June 23, 2015.
Identifiants
pubmed: 31113375
doi: 10.1186/s12879-019-4057-5
pii: 10.1186/s12879-019-4057-5
pmc: PMC6528321
doi:
Banques de données
ClinicalTrials.gov
['NCT02478905']
Types de publication
Journal Article
Langues
eng
Pagination
446Subventions
Organisme : Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
ID : 32003B_156902
Organisme : Bundesamt für Gesundheit (CH)
ID : 16.927730
Références
BMJ. 2001 Jan 20;322(7279):138
pubmed: 11159569
CMAJ. 2001 May 15;164(10):1413-9
pubmed: 11387913
Lancet Infect Dis. 2002 Mar;2(3):145-55
pubmed: 11944184
Occup Med (Lond). 2002 Aug;52(5):249-53
pubmed: 12181372
Eur Respir J. 2003 Feb;21(2):303-7
pubmed: 12608445
BMJ. 2005 Nov 12;331(7525):1145
pubmed: 16282424
Emerg Infect Dis. 2006 Jan;12(1):81-7
pubmed: 16494722
Am J Epidemiol. 2008 Apr 1;167(7):775-85
pubmed: 18230677
Am J Pharm Educ. 2008 Apr 15;72(2):43
pubmed: 18483608
MMWR Recomm Rep. 2008 Aug 8;57(RR-7):1-60
pubmed: 18685555
J Hosp Infect. 2009 Jan;71(1):1-14
pubmed: 18952319
J Infect Dis. 2010 May 15;201(10):1509-16
pubmed: 20377412
J Clin Microbiol. 2010 Sep;48(9):3340-2
pubmed: 20610685
PLoS One. 2011;6(6):e21335
pubmed: 21731708
Cochrane Database Syst Rev. 2011 Jul 06;(7):CD006207
pubmed: 21735402
PLoS Med. 2011 Jul;8(7):e1001053
pubmed: 21750667
Clin Infect Dis. 2016 Feb 15;62(4):438-9
pubmed: 26518470
J Clin Pharmacol. 2016 Sep;56(9):1151-64
pubmed: 26634893
Pediatr Infect Dis J. 2016 May;35(5):583-6
pubmed: 26910589
Trials. 2016 Oct 10;17(1):489
pubmed: 27724922
Influenza Other Respir Viruses. 2017 Jul;11(4):337-344
pubmed: 28380272
Lancet. 2017 Jul 15;390(10091):231-266
pubmed: 28528753
Mhealth. 2017 Nov 01;3:49
pubmed: 29184901
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716